viral vaccines

This may be used to produce viral vaccines or gene therapy vectors.

He has been awarded multiple patents on viral vaccines and antivirals.

The Gordons were doing brilliant work with viral vaccines."

This sort of reconstitution has been shown by others to greatly enhance the effectiveness of viral vaccines.

The experimental vaccine in the chimp experiments differs from most standard viral vaccines, which are derived from either dead or weakened viruses.

However, since viral vaccines contain only a small fraction of pathogen genes, they are much safer and sporadic infection by the pathogen is impossible.

If antibody function is normal, all routine childhood immunizations including live viral vaccines (measles, mumps, rubella and varicella) should be given.

Priming of cytotoxic cell responses is necessary for the design of therapeutic cancer vaccines, as well as for viral vaccines.

He became the program officer for the viral vaccines program in 1983, and the influenza and viral respiratory diseases program officer the next year.

Edited by Diane McLaren Contents Basic concepts and new aspects of vaccine development Strategies for viral vaccines: scientific challenge and regulatory aspects.

Immunocompromised individuals, such as HIV-infected persons, pregnant women, and those on systemic steroids, should not receive the live viral vaccines, varicella and MMR.

Most viral vaccines are based on live attenuated viruses, while many bacterial vaccines are based on acellular components of micro-organisms, including harmless toxin components.

In contrast, cell culture manufacturing technology can be applied to influenza vaccines as they are with most viral vaccines (e.g., polio vaccine, measles-mumps-rubella vaccine, chickenpox vaccine).

The cell culture media of some viral vaccines, and the virus of the rubella vaccine, are derived from tissues taken from therapeutic abortions performed in the 1960s, leading to moral questions.

She has received numerous awards and has several patents to her name relating to viral vaccines, proteins, and vectors including the IRES of EMCV.

Jean Stéphenne joined SmithKline-RIT (now GlaxoSmithKline Biologicals) in 1974 as head of bacterial and viral vaccines production, he became Vaccine Production Director in 1980.

In 1981 he left the National Cancer Institute to be Research Director at Molecular Genetics Incorporated in Minnetonka, Minnesota where he worked on recombinant DNA based viral vaccines.

Cell culture (cell-based) manufacturing technology can be applied to influenza vaccines as they are with most viral vaccines and thereby solve the problems associated with creating flu vaccines using chicken eggs as is currently done.

For example, the production of viral vaccines, recombinant proteins using viral vectors and viral antigens all require virus quantification to continually adapt and monitor the process in order to optimize production yields and respond to ever changing demands and applications.